Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Схожие документы

• Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
  по: Shiwen, X, и др.
  Опубликовано: (2006)
• Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
  по: S. Soldano, и др.
  Опубликовано: (2011-01-01)
• Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
  по: Alix Naert, и др.
  Опубликовано: (2013-01-01)
• CTGF overexpressing mice: a model for human scleroderma
  по: Sonnylal, S, и др.
  Опубликовано: (2006)
• Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
  по: Emma Di Poi, и др.
  Опубликовано: (2023-11-01)